Market Place
Upload your Marketing & Sales content on your company Virtual Booth, click HERE
X
Please Wait
Applying Filters...
01 Patheon Italia S.p.A. (3)
01 romiplostim (3)
01 U.S.A (3)
100
PharmaCompass offers a list of Semaxanib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Semaxanib manufacturer or Semaxanib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Semaxanib manufacturer or Semaxanib supplier.
PharmaCompass also assists you with knowing the Semaxanib API Price utilized in the formulation of products. Semaxanib API Price is not always fixed or binding as the Semaxanib Price is obtained through a variety of data sources. The Semaxanib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Su 5416 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Su 5416, including repackagers and relabelers. The FDA regulates Su 5416 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Su 5416 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Su 5416 supplier is an individual or a company that provides Su 5416 active pharmaceutical ingredient (API) or Su 5416 finished formulations upon request. The Su 5416 suppliers may include Su 5416 API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Su 5416 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Su 5416 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Su 5416 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Su 5416 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Su 5416 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Su 5416 suppliers with NDC on PharmaCompass.
